SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Simone Vasilij Benatti, Quinzan Giampaolo, Bigoni Sara, Rizzi Marco, Ripamonti Diego, Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients, AIDS, 2014, 28, 17, 2633

    CrossRef

  2. 2
    Elisa Calabrò, Maurizio Zompatori, Venerino Poletti, Dario Olivieri, Desquamative Interstitial Pneumonitis (DIP) occurring during treatment with pegylated interferon and ribavirin, Respiratory Medicine CME, 2009, 2, 2, 77

    CrossRef

  3. 3
    E. Laffitte, B. Genton, R.G. Panizzon, Cutaneous Leishmaniasis Caused by <i>Leishmania tropica:</i> Treatment with Oral Fluconazole, Dermatology, 2005, 210, 3, 249

    CrossRef

  4. 4
    J. Puente V&aacute;zquez, F. Moreno Ant&oacute;n, E. Grande Pulido, S. L&oacute;pez Tarruella-Cobo, P. P&eacute;rez Segura, E. D&iacute;az-Rubio, Interstitial Pneumonitis and Lung Fibrosis during Adjuvant Treatment of Melanoma with Interferon Alpha according to the Kirkwood Schedule, Dermatology, 2005, 210, 3, 247

    CrossRef

  5. 5
    Kelly J Butnor, Pulmonary Sarcoidosis Induced by Interferon-?? Therapy, The American Journal of Surgical Pathology, 2005, 29, 7, 976

    CrossRef

  6. 6
    Sotirios Tsiodras, Panagiota Drimala, Nick Stavreas, Marios Dachlythras, Anna Maria Alamani, George Naoum, Uterine Sarcoidosis Potentially Associated With Interferon-α Use for Chronic Hepatitis C Infection, Obstetrics & Gynecology, 2005, 105, Supplement, 1198

    CrossRef

  7. 7
    John Midturi, Miguel Sierra-Hoffman, Douglas Hurley, Richard Winn, Robert Beissner, John Carpenter, Spectrum of Pulmonary Toxicity Associated with the Use of Interferon Therapy for Hepatitis C: Case Report and Review of the Literature, Clinical Infectious Diseases, 2004, 39, 11, 1724

    CrossRef

  8. 8
    Petr Husa, Jarmila Klusáková, Jana Jančı́ková, Libuše Husová, František Horálek, Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis B, European Journal of Internal Medicine, 2002, 13, 2, 129

    CrossRef

  9. 9
    Anuchit Chutaputti, Adverse effects and other safety aspects of the hepatitis C antivirals, Journal of Gastroenterology and Hepatology, 2000, 15,
  10. 10
    F.L. Dumoulin, L. Leifeld, T. Sauerbruch, U. Spengler, Autoimmunity induced by interferon-α therapy for chronic viral hepatitis, Biomedicine & Pharmacotherapy, 1999, 53, 5-6, 242

    CrossRef

  11. 11
    Masayuki Hanaoka, Keishi Kubo, Toshihide Hayano, Tomonobu Koizumi, Toshio Kobayashi, Interferon-α elevates pulmonary blood pressure in sheep—the role of thromboxane cascade, European Journal of Pharmacology, 1999, 370, 2, 145

    CrossRef

  12. 12
    Edmund J. Bini, Elizabeth H. Weinshel, Severe Exacerbation of Asthma: A New Side Effect of Interferon-α in Patients With Asthma and Chronic Hepatitis C, Mayo Clinic Proceedings, 1999, 74, 4, 367

    CrossRef

  13. 13
    Robert M. Hoffmann, Maria-Christina Jung, Reinhard Motz, Christoph Göβl, Hans-Peter Emslander, Reinhard Zachoval, Gerd R. Pape, Sarcoidosis associated with interferon-α therapy for chronic hepatitis C, Journal of Hepatology, 1998, 28, 6, 1058

    CrossRef

  14. 14
    Thierry Vial, Jacques Descotes, 1995,

    CrossRef